OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

MicroRNAs in Tumor Cell Metabolism: Roles and Therapeutic Opportunities
Abraham Pedroza‐Torres, Sandra Romero‐Córdoba, Montserrat Justo-Garrido, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 79

Showing 1-25 of 79 citing articles:

Revisiting the Warburg effect: historical dogma versus current understanding
Peter Vaupel, Gabriele Multhoff
The Journal of Physiology (2020) Vol. 599, Iss. 6, pp. 1745-1757
Open Access | Times Cited: 584

Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention
Lisa M. Butler, Ylenia Perone, Jonas Dehairs, et al.
Advanced Drug Delivery Reviews (2020) Vol. 159, pp. 245-293
Open Access | Times Cited: 472

Hallmarks of cancer resistance
Muhammad Tufail, Jia-Ju Hu, Jie Liang, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109979-109979
Open Access | Times Cited: 24

Dichloroacetate restores colorectal cancer chemosensitivity through the p53/miR-149-3p/PDK2-mediated glucose metabolic pathway
Yu Liang, Lidan Hou, Linjing Li, et al.
Oncogene (2019) Vol. 39, Iss. 2, pp. 469-485
Open Access | Times Cited: 92

The effect of metformin therapy on incidence and prognosis in prostate cancer: A systematic review and meta-analysis
Kancheng He, Huating Hu, Senlin Ye, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 78

Long non-coding RNA DLEU2 drives EMT and glycolysis in endometrial cancer through HK2 by competitively binding with miR-455 and by modulating the EZH2/miR-181a pathway
Peixin Dong, Ying Xiong, Yosuke Konno, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 69

miRNA-Based Technologies in Cancer Therapy
Maria Pagoni, Claudia Cava, Diamantis C. Sideris, et al.
Journal of Personalized Medicine (2023) Vol. 13, Iss. 11, pp. 1586-1586
Open Access | Times Cited: 37

FOXO3a/miR-4259-driven LDHA expression as a key mechanism of gemcitabine sensitivity in pancreatic ductal adenocarcinoma
Tung‐Wei Hsu, Wanyu Wang, Hsin‐An Chen, et al.
Cancer & Metabolism (2025) Vol. 13, Iss. 1
Open Access | Times Cited: 1

Interactions between the MicroRNAs and Microbiota in Cancer Development: Roles and Therapeutic Opportunities
Alessandro Allegra, Caterina Musolino, Alessandro Tonacci, et al.
Cancers (2020) Vol. 12, Iss. 4, pp. 805-805
Open Access | Times Cited: 51

Small non-coding RNAs in human cancer: function, clinical utility, and characterization
Zhao Zhang, Jian Zhang, Lixia Diao, et al.
Oncogene (2021) Vol. 40, Iss. 9, pp. 1570-1577
Closed Access | Times Cited: 51

miRNAs in Regulation of Tumor Microenvironment, Chemotherapy Resistance, Immunotherapy Modulation and miRNA Therapeutics in Cancer
Kousain Kousar, Tahir Ahmad, Maisa Siddiq Abduh, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 13822-13822
Open Access | Times Cited: 30

The role of noncoding RNAs in metabolic reprogramming of cancer cells
Amir Safi, Mohammadreza Saberiyan, Mohammad‐Javad Sanaei, et al.
Cellular & Molecular Biology Letters (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 16

Prostate cancer biomarkers: from early diagnosis to precision treatment
Versha Dahiya, Sanjana Hans, Ruchi Kumari, et al.
Clinical & Translational Oncology (2024) Vol. 26, Iss. 10, pp. 2444-2456
Closed Access | Times Cited: 5

The Role of miRNA for the Treatment of MGMT Unmethylated Glioblastoma Multiforme
Anna Kirstein, Thomas E. Schmid, Stephanie E. Combs
Cancers (2020) Vol. 12, Iss. 5, pp. 1099-1099
Open Access | Times Cited: 34

Regulators at Every Step—How microRNAs Drive Tumor Cell Invasiveness and Metastasis
Tomasz M. Grzywa, Klaudia Klicka, Paweł Włodarski
Cancers (2020) Vol. 12, Iss. 12, pp. 3709-3709
Open Access | Times Cited: 34

The Role of miRNAs in the Development, Proliferation, and Progression of Endometrial Cancer
Anna Bogaczyk, Izabela Zawlik, Tomasz Zuzak, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 14, pp. 11489-11489
Open Access | Times Cited: 11

MicroRNAs in cancer therapy: Their involvement in oxaliplatin sensitivity/resistance of cancer cells with a focus on colorectal cancer
Milad Ashrafizadeh, Ali Zarrabi, Kiavash Hushmandi, et al.
Life Sciences (2020) Vol. 256, pp. 117973-117973
Closed Access | Times Cited: 30

miRNAs as Molecular Biomarkers for Prostate Cancer
Donatella Coradduzza, Tatiana Solinas, Francesca Balzano, et al.
Journal of Molecular Diagnostics (2022) Vol. 24, Iss. 11, pp. 1171-1180
Open Access | Times Cited: 18

Beyond the genome: lncRNAs as regulators of the PI3K/AKT pathway in lung cancer
Waleed Hassan Almalki
Pathology - Research and Practice (2023) Vol. 251, pp. 154852-154852
Closed Access | Times Cited: 10

Soy Isoflavone Genistein Enhances Tamoxifen Sensitivity in Breast Cancer via microRNA and Glucose Metabolism Modulation
Jessica Shpigel, Eliete Luciano, Blessing Ukandu, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 2, pp. 733-733
Open Access

MiR-326: Role and significance in brain cancers
Zaira Spinello, Zein Mersini Besharat, Fabrizio Mainiero, et al.
Non-coding RNA Research (2025) Vol. 12, pp. 56-64
Open Access

MicroRNA-665 and its potential role in drug response and survival outcomes in multiple myeloma: a preliminary study
Rui Bergantim, Sara Peixoto da Silva, Vanessa Carla Monteiro Pinto, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access

Page 1 - Next Page

Scroll to top